SCHEMBL6710220

SCHEMBL6710220

Cn1c(C(=O)Nc2ccc(Br)cc2-c2noc(=O)[nH]2)cc2ccc(OCc3ccccc3)cc21

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 2/20 0.42
NPC1 O15118 1/20 0.36
TSHR P16473 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDM1A O60341 5/20 0.36
MAOA P21397 4/20 0.36
RCOR1 Q9UKL0 3/20 0.36
MAOB P27338 2/20 0.36
MAPT P10636 1/20 0.36
SRD5A1 P18405 1/20 0.35
SMPD1 P17405 1/20 0.35
GRIK1 P39086 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
LRRK2 Q5S007 1/20 0.35
EPHB3 P54753 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6709188 0.91 SRD5A2 (0.42) SRD5A2KDM1AMAOARCOR1MAOB
SCHEMBL7126152 0.89 PDGFRB (0.42) SRD5A2NPC1RAB9AKDM1AMAOA
SCHEMBL6918878 0.89 TDP2 (0.45) SRD5A2KDM1AMAOARCOR1MAOB
SCHEMBL6713703 0.88 AKR1C2 (0.40) NPC1RAB9ASMN1; SMN2MAPTSMPD1
SCHEMBL6709833 0.87 MAPT (0.42) NPC1TSHRRAB9ASMN1; SMN2MAPT
SCHEMBL6710387 0.86 TDP2 (0.43) SRD5A2SMN1; SMN2KDM1AMAOAMAOB
SCHEMBL6713543 0.86 KDM1A (0.41) KDM1AMAOARCOR1
SCHEMBL6707730 0.85 KDM1A (0.40) KDM1AMAOARCOR1
SCHEMBL6708956 0.85 LRRK2 (0.38) MAPTGRIK1LRRK2
SCHEMBL6713546 0.85 HSP90AB1 (0.35) NPC1RAB9ASMN1; SMN2MAPTGRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 SRD5A2 873/4885NPC1 3891/4885TSHR 3901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.